Renovaro Stock Discussion

1. $Renovaro (RENB.US)$Renovaro Biosciences (NASDAQ: RENB)
Renovaro focuses on AI-driven healthcare innovation, particularly in early cancer detection and immunotherapy. Their flagship product, RenovaroCube, uses AI for diagnostics. The company has also acquired GEDi Cube and formed partnerships with institutions like Amsterdam UMC Cancer Center. Recent restructuring includes appointing David Weinstein as CEO .
2. $Rigetti Computing (RGTI.US)$Rigetti Co...

$Renovaro (RENB.US)$
keeping my eyes on this one

$Renovaro (RENB.US)$
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
RenovaroCube (NASDAQ: RENB), a leader in AI-driven cancer diagnostics, presented groundbreaking research at the Molecular Analysis for Precision Oncology Congress on October 16, 2024. The study explores the use of Oxford Nanopore sequencing on circulating cell-free DNA (cfDNA) from blood plasma to detect copy number alterations (CNAs) in lung cancer patients.
Key findi...

$Renovaro (RENB.US)$ 🤔

$Renovaro (RENB.US)$ NASDAQ:RENB) PersonalAIze and RenovaroCube are proud to announce a strategic partnership to develop, validate, and commercialize Cube's AI-driven, multi-omic platform for early detection of cancer and other diseases. This strategic partnership aims to provide services to many AI companies and healthcare systems while also creating the next generation of medical diagnostics through cutting-edge AI by driving greater accuracy, transparency, and trust in healthcare solutio...

$Renovaro (RENB.US)$ Independent Expert Assessment Validates RenovaroCube's Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
Globe Newswire 17-Sep-2024 9:00 AM